Skip to search.
 FTSE 100 Up 0.76%

VIVUS Inc. (VVUS)

-NasdaqGS
1.81 Up 0.11(6.47%) 28 Jul 21:00
Add to Portfolio
Prev Close:1.70
Open:1.74
Bid:0.01 x 100
Ask:2.18 x 1000
1y Target Est:4.50
Beta:1.48
Next Earnings Date:30-Jul-15VVUS Earnings announcement
Day's Range:1.61 - 1.83
52wk Range:1.61 - 5.13
Volume:1,367,509
Avg Vol (3m):1,001,970
Market Cap:187.91m
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSUp 6.47%187.91m
LLYUp 1.82%90.74b
GSKUp 0.26%100.73b
PFEUp 2.94%217.67b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.84
Quarterly EPS Est (Jun-15) :-0.24
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-2.63

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback